Prognostic significance of tumor subtypes in male breast cancer: a population-based study Leone JP, Leone J, Zwenger AO, Iturbe J, Vallejo CT, Leone BA. Breast Cancer Res Treat. 2015 Jul 1. [Epub ahead of print] […]
Black/White Disparities in Receipt of Treatment and Survival Among Men With Early-Stage Breast Cancer Sineshaw HM, Freedman RA, Ward EM, Flanders WD, Jemal A J Clin Oncol. 2015 May 4. pii: JCO.2014.60.5584. [Epub ahead of […]
CYP2D6*4 polymorphism: A new marker of response to hormonotherapy in male breast cancer? Abreu MH, Gomes M, Menezes F, Afonso N, Abreu PH, Medeiros R, Pereira D, Lopes C. Breast. 2015 Aug;24(4):481-6. doi: 10.1016/j.breast.2015.04.010. Epub […]
5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer Robinson D, Garmo H, Holmberg L, Stattin P Cancer Causes Control. 2015 Jun 25. [Epub ahead of print] PMID: 26109464 Background I show this […]
Aromatase inhibitors in male breast cancer: a pooled analysis Zagouri F, Sergentanis TN, Azim HA Jr, Chrysikos D, Dimopoulos MA, Psaltopoulou T Breast Cancer Res Treat. 2015 May;151(1):141-7. doi: 10.1007/s10549-015-3356-9. Epub 2015 Apr 8. Background […]
Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk Brinton LA, Key TJ, Kolonel LN, Michels KB, Sesso HD, Ursin G, Van Den Eeden SK, Wood SN, Falk RT, Parisi D, Guillemette C, […]
A novel PALB2 truncating mutation in an Italian family with male breast cancer Vietri MT, Caliendo G, Casamassimi A, Cioffi M, De Paola ML, Napoli C, Molinari AM Oncol Rep. 2015 Mar;33(3):1243-7. doi: 10.3892/or.2014.3685. Epub […]
Identification of a new BRCA2 large genomic deletion associated with high risk male breast cancer Timoteo AR, Albuquerque BM, Moura PC, Ramos CC, Agnez-Lima LF, Walsh T, King MC, Lajus TB Hered Cancer Clin Pract. […]
Estrogen receptor mutations and their role in breast cancer progression Prasanna G Alluri, Corey Speers and Arul M Chinnaiyan Breast Cancer Research 2014, 16:494 doi:10.1186/s13058-014-0494-7 Background About 75% of breast cancers are hormone positive, and […]
Incidence of breast cancer in a cohort of 5,135 transgender veterans George R. Brown and Kenneth T. Jones Breast Cancer Res Treat DOI 10.1007/s10549-014-3213-2 Background Most breast cancers are hormone driven, at least at first, […]
